Elsherbeny, M.H.; Elkamhawy, A.; Nada, H.; Abdellattif, M.H.; Lee, K.; Roh, E.J.
Development of New Meridianin/Leucettine-Derived Hybrid Small Molecules as Nanomolar Multi-Kinase Inhibitors with Antitumor Activity. Biomedicines 2021, 9, 1131.
https://doi.org/10.3390/biomedicines9091131
AMA Style
Elsherbeny MH, Elkamhawy A, Nada H, Abdellattif MH, Lee K, Roh EJ.
Development of New Meridianin/Leucettine-Derived Hybrid Small Molecules as Nanomolar Multi-Kinase Inhibitors with Antitumor Activity. Biomedicines. 2021; 9(9):1131.
https://doi.org/10.3390/biomedicines9091131
Chicago/Turabian Style
Elsherbeny, Mohamed H., Ahmed Elkamhawy, Hossam Nada, Magda H. Abdellattif, Kyeong Lee, and Eun Joo Roh.
2021. "Development of New Meridianin/Leucettine-Derived Hybrid Small Molecules as Nanomolar Multi-Kinase Inhibitors with Antitumor Activity" Biomedicines 9, no. 9: 1131.
https://doi.org/10.3390/biomedicines9091131
APA Style
Elsherbeny, M. H., Elkamhawy, A., Nada, H., Abdellattif, M. H., Lee, K., & Roh, E. J.
(2021). Development of New Meridianin/Leucettine-Derived Hybrid Small Molecules as Nanomolar Multi-Kinase Inhibitors with Antitumor Activity. Biomedicines, 9(9), 1131.
https://doi.org/10.3390/biomedicines9091131